NCT07059273Withdrawn
A COPD Data Registry for Participants With Frequent Exacerbations
An Observational, Prospective, Real-world Data Registry in Chronic Obstructive Pulmonary Disease (COPD) Patients Suffering From Frequent Exacerbations (AIREIC)
Source: ClinicalTrials.gov · Last updated 22 Jun 2026
Brief summary (registry, in English)
This registry will collect data on COPD, including the course of disease, treatment patterns, and potential new therapies. The registry will also track the experience of participants and caregivers in clinical practice.
- Status (registry)
- Withdrawn
- Study type
- Observational
- Enrollment
- 0 (actual)
- First submitted
- 24 Jun 2025
- Start date
- 14 Sept 2026
- Primary completion date
- 1 May 2031
- Lead sponsor
- Hoffmann-La Roche
- Diseases
- COPD
- NCT number
- NCT07059273
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participating in any interventional drug trials
Other
- In palliative treatment
Who the study is looking for
- Diagnosis of COPD for at least 12 months
- On stable, standard of care (SoC) COPD maintenance therapy
- Have experienced at least 2 exacerbations (moderate or severe) in the last 12 months, with one of them occurring while on SoC therapy
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.